225 related articles for article (PubMed ID: 37139492)
21. Cellular Protein HuR Regulates the Switching of Genomic RNA Templates for Differential Functions during the Coxsackievirus B3 Life Cycle.
George B; Dave P; Rani P; Behera P; Das S
J Virol; 2021 Oct; 95(21):e0091521. PubMed ID: 34406862
[TBL] [Abstract][Full Text] [Related]
22. A Kidnapping Story: How Coxsackievirus B3 and Its Host Cell Interact.
Peischard S; Ho HT; Theiss C; Strutz-Seebohm N; Seebohm G
Cell Physiol Biochem; 2019; 53(1):121-140. PubMed ID: 31230428
[TBL] [Abstract][Full Text] [Related]
23. Activation of AMPK restricts coxsackievirus B3 replication by inhibiting lipid accumulation.
Xie W; Wang L; Dai Q; Yu H; He X; Xiong J; Sheng H; Zhang D; Xin R; Qi Y; Hu F; Guo S; Zhang K
J Mol Cell Cardiol; 2015 Aug; 85():155-67. PubMed ID: 26055448
[TBL] [Abstract][Full Text] [Related]
24.
Lee YG; Park JH; Jeon ES; Kim JH; Lim BK
J Microbiol Biotechnol; 2016 Nov; 26(11):2012-2018. PubMed ID: 27558433
[TBL] [Abstract][Full Text] [Related]
25. Activation of apoptotic signalling events in human embryonic stem cells upon Coxsackievirus B3 infection.
Romorini L; Scassa ME; Videla Richardson G; Blüguermann C; Jaquenod de Giusti C; Questa M; Fernandez Espinosa DD; Gómez RM; Sevlever GE; Miriuka SG
Apoptosis; 2012 Feb; 17(2):132-42. PubMed ID: 22012335
[TBL] [Abstract][Full Text] [Related]
26. Engineered coxsackievirus B3 containing multiple organ-specific miRNA targets showed attenuated viral tropism and protective immunity.
Xiao Z; He F; Feng M; Liu Z; Liu Z; Li S; Wang W; Yao H; Wu J
Infect Genet Evol; 2022 Sep; 103():105316. PubMed ID: 35718333
[TBL] [Abstract][Full Text] [Related]
27. Rapid Dissemination and Monopolization of Viral Populations in Mice Revealed Using a Panel of Barcoded Viruses.
McCune BT; Lanahan MR; tenOever BR; Pfeiffer JK
J Virol; 2020 Jan; 94(2):. PubMed ID: 31666382
[TBL] [Abstract][Full Text] [Related]
28. Coxsackievirus B3-induced calpain activation facilitates the progeny virus replication via a likely mechanism related with both autophagy enhancement and apoptosis inhibition in the early phase of infection: an in vitro study in H9c2 cells.
Li M; Wang X; Yu Y; Yu Y; Xie Y; Zou Y; Ge J; Peng T; Chen R
Virus Res; 2014 Jan; 179():177-86. PubMed ID: 24177271
[TBL] [Abstract][Full Text] [Related]
29. Specific Bacterial Cell Wall Components Influence the Stability of Coxsackievirus B3.
Dhalech AH; Fuller TD; Robinson CM
J Virol; 2021 Oct; 95(22):e0142421. PubMed ID: 34431699
[TBL] [Abstract][Full Text] [Related]
30. A food-responsive switch modulates TFEB and autophagy, and determines susceptibility to coxsackievirus infection and pancreatitis.
Alirezaei M; Flynn CT; Garcia SD; Kimura T; Whitton JL
Autophagy; 2021 Feb; 17(2):402-419. PubMed ID: 32019403
[TBL] [Abstract][Full Text] [Related]
31. Coxsackievirus preferentially replicates and induces cytopathic effects in undifferentiated neural progenitor cells.
Tsueng G; Tabor-Godwin JM; Gopal A; Ruller CM; Deline S; An N; Frausto RF; Milner R; Crocker SJ; Whitton JL; Feuer R
J Virol; 2011 Jun; 85(12):5718-32. PubMed ID: 21471247
[TBL] [Abstract][Full Text] [Related]
32. Virus-Host Interactions of Enteroviruses and Parvovirus B19 in Myocarditis.
Ho HT; Peischard S; Strutz-Seebohm N; Seebohm G
Cell Physiol Biochem; 2021 Nov; 55(6):679-703. PubMed ID: 34791861
[TBL] [Abstract][Full Text] [Related]
33. A Conserved Cysteine Residue in Coxsackievirus B3 Protein 3A with Implication for Elevated Virulence.
Voss M; Pinkert S; Kespohl M; Gimber N; Klingel K; Schmoranzer J; Laue M; Gaida M; Kloetzel PM; Beling A
Viruses; 2022 Apr; 14(4):. PubMed ID: 35458499
[TBL] [Abstract][Full Text] [Related]
34. Emergence of a Large-Plaque Variant in Mice Infected with Coxsackievirus B3.
Wang Y; Pfeiffer JK
mBio; 2016 Mar; 7(2):e00119. PubMed ID: 27025249
[TBL] [Abstract][Full Text] [Related]
35. Enterovirus 2Apro targets MDA5 and MAVS in infected cells.
Feng Q; Langereis MA; Lork M; Nguyen M; Hato SV; Lanke K; Emdad L; Bhoopathi P; Fisher PB; Lloyd RE; van Kuppeveld FJ
J Virol; 2014 Mar; 88(6):3369-78. PubMed ID: 24390337
[TBL] [Abstract][Full Text] [Related]
36. The protective role of microRNA-21 against coxsackievirus B3 infection through targeting the MAP2K3/P38 MAPK signaling pathway.
He F; Xiao Z; Yao H; Li S; Feng M; Wang W; Liu Z; Liu Z; Wu J
J Transl Med; 2019 Oct; 17(1):335. PubMed ID: 31585536
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
Zhou L; He X; Gao B; Xiong S
J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
[TBL] [Abstract][Full Text] [Related]
38. Over-expression of mitochondrial antiviral signaling protein inhibits coxsackievirus B3 infection by enhancing type-I interferons production.
Zhang QM; Song WQ; Li YJ; Qian J; Zhai AX; Wu J; Li AM; He JM; Zhao JY; Yu X; Wei LL; Zhang FM
Virol J; 2012 Dec; 9():312. PubMed ID: 23249700
[TBL] [Abstract][Full Text] [Related]
39. Astragaloside IV exerts antiviral effects against coxsackievirus B3 by upregulating interferon-gamma.
Zhang Y; Zhu H; Huang C; Cui X; Gao Y; Huang Y; Gong W; Zhao Y; Guo S
J Cardiovasc Pharmacol; 2006 Feb; 47(2):190-5. PubMed ID: 16495755
[TBL] [Abstract][Full Text] [Related]
40. Altered interactions between stem-loop IV within the 5' noncoding region of coxsackievirus RNA and poly(rC) binding protein 2: effects on IRES-mediated translation and viral infectivity.
Sean P; Nguyen JH; Semler BL
Virology; 2009 Jun; 389(1-2):45-58. PubMed ID: 19446305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
